Thon N - Search Results

1

Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma.

Fleischmann DF, Jenn J, Corradini S, Ruf V, Herms J, Forbrig R, Unterrainer M, Thon N, Kreth FW, Belka C, Niyazi M. Fleischmann DF, et al. Among authors: thon n. Radiother Oncol. 2019 Sep;138:99-105. doi: 10.1016/j.radonc.2019.06.009. Epub 2019 Jun 25. Radiother Oncol. 2019. PMID: 31252301

2

Expression of VEGFR3 in glioma endothelium correlates with tumor grade.

Grau SJ, Trillsch F, Herms J, Thon N, Nelson PJ, Tonn JC, Goldbrunner R. Grau SJ, et al. Among authors: thon n. J Neurooncol. 2007 Apr;82(2):141-50. doi: 10.1007/s11060-006-9272-4. Epub 2006 Nov 17. J Neurooncol. 2007. PMID: 17115285

3

Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomas.

Thon N, Eigenbrod S, Grasbon-Frodl EM, Ruiter M, Mehrkens JH, Kreth S, Tonn JC, Kretzschmar HA, Kreth FW. Thon N, et al. J Neuropathol Exp Neurol. 2009 Nov;68(11):1219-28. doi: 10.1097/NEN.0b013e3181bee1f1. J Neuropathol Exp Neurol. 2009. PMID: 19816195

4

The place of interstitial brachytherapy and radiosurgery for low-grade gliomas.

Kreth FW, Thon N, Siefert A, Tonn JC. Kreth FW, et al. Among authors: thon n. Adv Tech Stand Neurosurg. 2010;35:183-212. doi: 10.1007/978-3-211-99481-8_7. Adv Tech Stand Neurosurg. 2010. PMID: 20102115 Review.

5

Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide.

Thon N, Eigenbrod S, Grasbon-Frodl EM, Lutz J, Kreth S, Popperl G, Belka C, Kretzschmar HA, Tonn JC, Kreth FW. Thon N, et al. J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):441-6. doi: 10.1136/jnnp.2010.214593. Epub 2010 Sep 22. J Neurol Neurosurg Psychiatry. 2011. PMID: 20861061

6

Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.

Kunz M, Thon N, Eigenbrod S, Hartmann C, Egensperger R, Herms J, Geisler J, la Fougere C, Lutz J, Linn J, Kreth S, von Deimling A, Tonn JC, Kretzschmar HA, Pöpperl G, Kreth FW. Kunz M, et al. Among authors: thon n. Neuro Oncol. 2011 Mar;13(3):307-16. doi: 10.1093/neuonc/noq196. Epub 2011 Feb 3. Neuro Oncol. 2011. PMID: 21292686 Free PMC article.

7

O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation.

Kreth S, Thon N, Eigenbrod S, Lutz J, Ledderose C, Egensperger R, Tonn JC, Kretzschmar HA, Hinske LC, Kreth FW. Kreth S, et al. Among authors: thon n. PLoS One. 2011 Feb 18;6(2):e17156. doi: 10.1371/journal.pone.0017156. PLoS One. 2011. PMID: 21365007 Free PMC article.

8

Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.

Felsberg J, Thon N, Eigenbrod S, Hentschel B, Sabel MC, Westphal M, Schackert G, Kreth FW, Pietsch T, Löffler M, Weller M, Reifenberger G, Tonn JC; German Glioma Network. Felsberg J, et al. Among authors: thon n. Int J Cancer. 2011 Aug 1;129(3):659-70. doi: 10.1002/ijc.26083. Int J Cancer. 2011. PMID: 21425258

9

Iodine-125 brachytherapy for brain tumours--a review.

Schwarz SB, Thon N, Nikolajek K, Niyazi M, Tonn JC, Belka C, Kreth FW. Schwarz SB, et al. Among authors: thon n. Radiat Oncol. 2012 Mar 6;7:30. doi: 10.1186/1748-717X-7-30. Radiat Oncol. 2012. PMID: 22394548 Free PMC article. Review.

10

Epigenetics in human gliomas.

Kreth S, Thon N, Kreth FW. Kreth S, et al. Among authors: thon n. Cancer Lett. 2014 Jan 28;342(2):185-92. doi: 10.1016/j.canlet.2012.04.008. Epub 2012 Apr 21. Cancer Lett. 2014. PMID: 22531315 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters